JORGE E CORTES to Electrocardiography
This is a "connection" page, showing publications JORGE E CORTES has written about Electrocardiography.
Connection Strength
0.090
-
Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status. J Clin Oncol. 2013 Oct 10; 31(29):3681-7.
Score: 0.072
-
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignancies. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1599-607.
Score: 0.018